Context Therapeutics Inc.

NASDAQ: CNTX · Real-Time Price · USD
0.65
0.10 (17.84%)
At close: Jun 06, 2025, 3:59 PM
0.66
2.17%
After-hours: Jun 06, 2025, 05:41 PM EDT

Context Therapeutics Statistics

Share Statistics

Context Therapeutics has 89.7M shares outstanding. The number of shares has increased by 19.61% in one year.

89.7M
19.61%
19.61%
90.44%
n/a
343
0.19%

Short Selling Information

The latest short interest is 2.27M, so 2.54% of the outstanding shares have been sold short.

2.27M
2.54%
3.08%
32.8

Valuation Ratios

The PE ratio is -2.3 and the forward PE ratio is -1.65. Context Therapeutics's PEG ratio is 0.03.

-2.3
-1.65
0
0.8
0.64
-2.09
0.03
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Context Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 35.62, with a Debt / Equity ratio of 0.

35.62
35.62
0
-0.01
-0.01
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-2,227,092
12
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -61.99% in the last 52 weeks. The beta is 1.86, so Context Therapeutics's price volatility has been higher than the market average.

1.86
-61.99%
0.74
1.31
46.58
179,257

Income Statement

n/a
n/a
-29.92M
-26.73M
-26.67M
-26.73M
-0.46
Full Income Statement

Balance Sheet

The company has 94.43M in cash and 219.38K in debt, giving a net cash position of 94.21M.

94.43M
219.38K
94.21M
-94.78M
92.97M
90.83M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.56M and capital expenditures -14.76M, giving a free cash flow of -29.31M.

-14.56M
-14.76M
-29.31M
-0.5
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

CNTX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for CNTX is $5, which is 669.2% higher than the current price. The consensus rating is "Buy".

$5
669.2%
Buy
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

16
2